Ultralow-Dose Adjunctive Methadone with Slow Titration, Considering Long Half-Life, for Outpatients with Cancer-Related Pain

Background: The unique properties of methadone make it attractive for use in cancer pain. The use of very low initial doses of adjunctive methadone is a promising strategy given its simplicity and potentially reduced risk profile. Objective: To understand if an ultralow-dose (ULD) methadone protocol...

Full description

Bibliographic Details

Published in:	Palliative Medicine Reports
Main Authors:	Srini Chary, Amane Abdul-Razzak, Lyle Galloway
Format:	Article
Language:	English
Published:	Mary Ann Liebert 2020-07-01
Subjects:	analgesia cancer pain methadone pain palliative care
Online Access:	https://www.liebertpub.com/doi/full/10.1089/PMR.2020.0034